Results 141 to 150 of about 3,975 (165)

Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017-2024): a retrospective cohort study. [PDF]

J Comp Eff Res
Mordi U, Christoph MJ, Chastek B, Lim T, Neia Prata Menezes, Majethia S, Le LB, Cohen J.   +7 more
europepmc   +1 more source

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy. [PDF]

HIV Med
Sheridan R, Osei-Kuffour Ekert Y, Campbell L, Zuckerman M, Hawkins S, Childs K, Post FA.   +6 more
europepmc   +1 more source

Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV. [PDF]

AIDS
Zhao D, Sun L, Cen P, He Y, Zhao F, Li X, Luo Y, Xiao X, Liu C, Jiang Y, Wu H, Gong W, Li Y, Liu J.   +13 more
europepmc   +1 more source

A Robust and Accurate Filter Paper-Based Dried Plasma Spot Method for Bictegravir Monitoring in HIV Therapy. [PDF]

Rapid Commun Mass Spectrom
Sathyanarayanan A, Arekal RN, Somashekara D.   +2 more
europepmc   +1 more source

Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV. [PDF]

J Health Econ Outcomes Res
Chastek B, Mordi U, Christoph MJ, Le LB, Lim T, Majethia S, Trom C, Cohen J.   +7 more
europepmc   +1 more source